Literature DB >> 10413203

Antiphospholipid (Hughes') syndrome in African-Americans: IgA aCL and abeta2 glycoprotein-I is the most frequent isotype.

E Diri1, E Cucurull, A E Gharavi, D Kapoor, E A Mendez, E Scopelitis, W A Wilson.   

Abstract

Antiphospholipid (Hughes') syndrome (APS) has not been reported in African-Americans (A-A) as frequently as in other ethnic groups. We describe eight A-A female patients with APS, including two cases of primary APS (PAPS), four with APS secondary to systemic lupus erythematosus (SLE), one with Sjögren's syndrome, and one with overlap connective tissue disease (CTD). Their mean age was 34 y (range 24-47 y). Patients were followed for a mean of 6 y (range 0.3-11 y). During follow up, both anticardiolipin (aCL) and anti-beta2glycoprotein-I (abeta2GPI) antibodies were measured in stored sera by enzyme-linked immunosorbent assay (ELISA). IgA was the most frequent isotype of aCL and abeta2GPI, and co-occurred with the IgM isotype in three of four patients with neurologic manifestations.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413203     DOI: 10.1191/096120399678847812

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  14 in total

1.  High frequency of antiphospholipid antibodies in primary biliary cirrhosis.

Authors:  Amani Mankaï; Wiem Manoubi; Mariam Ghozzi; Sarra Melayah; Wahiba Sakly; Ibtissem Ghedira
Journal:  J Clin Lab Anal       Date:  2014-03-28       Impact factor: 2.352

Review 2.  Diagnosis of the antiphospholipid syndrome: how far to go?

Authors:  Joan T Merrill
Journal:  Curr Rheumatol Rep       Date:  2004-12       Impact factor: 4.592

Review 3.  Ethnic and geographical variation in antiphospholipid (Hughes) syndrome.

Authors:  I Uthman; M Khamashta
Journal:  Ann Rheum Dis       Date:  2005-05-26       Impact factor: 19.103

Review 4.  Clinical Risk Assessment in the Antiphospholipid Syndrome: Current Landscape and Emerging Biomarkers.

Authors:  Shruti Chaturvedi; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2017-07       Impact factor: 4.592

5.  Functional expression of IgA receptor FcalphaRI on human platelets.

Authors:  Kun Qian; Fenglong Xie; Andrew W Gibson; Jeffrey C Edberg; Robert P Kimberly; Jianming Wu
Journal:  J Leukoc Biol       Date:  2008-09-10       Impact factor: 4.962

Review 6.  Recent advances in the diagnosis of antiphospholipid syndrome.

Authors:  Hyun-Sook Chi
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  Anti Saccharomyces cerevisiae Antibodies in Patients With Anti-β2 Glycoprotein I Antibodies.

Authors:  Amani Mankaï; Skander Layouni; Ibtissem Ghedira
Journal:  J Clin Lab Anal       Date:  2016-04-07       Impact factor: 2.352

8.  Independent association of anti-beta(2)-glycoprotein I antibodies with macrovascular disease and mortality in scleroderma patients.

Authors:  Francesco Boin; Stefano Franchini; Elizabeth Colantuoni; Antony Rosen; Fredrick M Wigley; Livia Casciola-Rosen
Journal:  Arthritis Rheum       Date:  2009-08

9.  Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.

Authors:  Vijaya Murthy; Rohan Willis; Zurina Romay-Penabad; Patricia Ruiz-Limón; Laura A Martínez-Martínez; Shraddha Jatwani; Praveen Jajoria; Alan Seif; Graciela S Alarcón; Elizabeth Papalardo; Jigna Liu; Luis M Vilá; Gerald McGwin; Terry A McNearney; Rashmi Maganti; Prashanth Sunkureddi; Trisha Parekh; Michael Tarantino; Ehtisham Akhter; Hong Fang; Emilio B Gonzalez; Walter R Binder; Gary L Norman; Zakera Shums; Marius Teodorescu; John D Reveille; Michelle Petri; Silvia S Pierangeli
Journal:  Arthritis Rheum       Date:  2013-12

Review 10.  Clinical significance of IgA anti-cardiolipin and IgA anti-β2glycoprotein I antibodies.

Authors:  Laura Andreoli; Micaela Fredi; Cecilia Nalli; Silvia Piantoni; Rossella Reggia; Francesca Dall'Ara; Franco Franceschini; Angela Tincani
Journal:  Curr Rheumatol Rep       Date:  2013-07       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.